Opioids, scope: Treatment with (buprenorphine+naloxone), films or tabs?

Susan Fahmi Abu Dayeh; Mansour Moh’d kheir Abdel Razzaq Bader; Osama Saleh Faleh Al -Dib’I

doi:10.33545/26648962.2025.v7.i1b.92

Opioids, scope: Treatment with (buprenorphine+naloxone), films or tabs?

Author(s):

Susan Fahmi Abu Dayeh, Mansour Moh’d kheir Abdel Razzaq Bader and Osama Saleh Faleh Al -Dib’I

Abstract:

45 male patients who were diagnosed with Opioid use disorder, were observed and followed up from 21/2/2023 until 29/6/2024, after their consents required of being involved in this study. This study is made to recognise which type of medication (films or tabs) preferred by the patients. The medication is (buprenorphine+naloxone); which is called Suboxone; used in cases of opioids use disroder.

DOI: 10.33545/26648962.2025.v7.i1b.92

Pages: 122-123 | 266 Views 196 Downloads

Download (674KB)

International Journal of Psychiatry Research

How to cite this article:

Susan Fahmi Abu Dayeh, Mansour Moh’d kheir Abdel Razzaq Bader and Osama Saleh Faleh Al -Dib’I. Opioids, scope: Treatment with (buprenorphine+naloxone), films or tabs?. Int. J. Psychiatry Res. 2025;7(1):122-123. DOI: 10.33545/26648962.2025.v7.i1b.92

Vol. 7, Issue 1, Part B (2025)

Opioids, scope: Treatment with (buprenorphine+naloxone), films or tabs?

Related Links

Related Journal Subscription

Important Links